Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy

---

Yavas G., Celik E., Yavas C., Elsurer C., Afsar R.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, cilt.22, sa.4, ss.295-302, 2017 (ESCI, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 22 Sayı: 4
• Basım Tarihi: 2017
• Doi Numarası: 10.1016/j.rpor.2017.01.004
• Dergi Adı: REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
• Sayfa Sayıları: ss.295-302
• Süleyman Demirel Üniversitesi Adresli: Hayır

Özet

Aim: We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T).